Report: US health-related R&D spending increases while CDC budget is down 11%

23 December 2013
researchamerica-big

Health-related research and development spending in the USA increased 3.5% by $4.3 billion in 2011-12, according to a new report from Research!America.

Truth and Consequences: Health R&D Spending in the U.S. (FY11-12) says the spending increase was largely driven by industry, philanthropy and voluntary health associations as well as changes in the classification of spending within a few federal agencies.

Research!America’s chair John Porter said: “Industry, philanthropic and voluntary health association R&D spending increases offer a glimmer of hope in this dark era for medical research. Stagnant federal investments jeopardize our nation’s ability to advance medical progress and fuel private sector innovation, a catalyst for job creation and economic recovery.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical